This study delves into the potential of RNA profiling, specifically examining HER2, ESR1, and AR mRNA levels, providing nuanced insights for precise therapeutic interventions and outcome predictions in breast cancer.
Irvine, California– December 6, 2021 – Genomic Testing Cooperative, LCA (GTC) announced the presentation of four innovative studies at the annual American Society of Hematology (ASH) meeting that will be held from December 10 to 13, 2022 in New Orleans, Louisiana. The studies highlight and validate the value of the
Abstract Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap clinically. Using machine learning, we developed an approach to stratify patients with DLBCL into four subgroups based on survival characteristics. This approach uses data from
